Zobrazeno 1 - 10
of 328
pro vyhledávání: '"Ron Wald"'
Autor:
Suvi T. Vaara, MD, PhD, Ary Serpa Neto, MD, PhD, Rinaldo Bellomo, MD, PhD, Neill K. J. Adhikari, MDCM, MSc, Didier Dreyfuss, MD, PhD, Martin Gallagher, MD, PhD, Stephane Gaudry, MD, PhD, Eric Hoste, MD, PhD, Michael Joannidis, MD, Ville Pettilä, MD, PhD, Amanda Y. Wang, MD, PhD, Kianoush Kashani, MD, PhD, Ron Wald, MDCM, MPH, Sean M. Bagshaw, MD, MSc, Marlies Ostermann, MD, PhD, Sean M Bagshaw
Publikováno v:
Critical Care Explorations, Vol 6, Iss 2, p e1053 (2024)
OBJECTIVES:. Among patients with severe acute kidney injury (AKI) admitted to the ICU in high-income countries, regional practice variations for fluid balance (FB) management, timing, and choice of renal replacement therapy (RRT) modality may be sign
Externí odkaz:
https://doaj.org/article/2a1c155b95d6476f912d3bab80f84a29
Autor:
Cameron Giles, Milica Novakovic, Wilma Hopman, Erin F. Barreto, William Beaubien-Souligny, Peter Birks, Javier A. Neyra, Ron Wald, Samuel A. Silver
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 10 (2023)
Background: Acute kidney injury (AKI) increases the risk of hospital readmission, chronic kidney disease, and death. Therefore, effective communication in discharge summaries is essential for safe transitions of care. Objective: The objectives of thi
Externí odkaz:
https://doaj.org/article/0a9c1cd3b067416799098ca89e37feb7
Autor:
Rachel Jeong, Matthew T. James, Robert R. Quinn, Pietro Ravani, Sean M. Bagshaw, Henry T. Stelfox, Neesh Pannu, Alix Clarke, Ron Wald, Tyrone G. Harrison, Daniel J. Niven, Ngan N. Lam
Publikováno v:
Kidney Medicine, Vol 5, Iss 8, Pp 100685- (2023)
Rationale & Objective: To evaluate follow-up care of critically ill patients with acute kidney injury (AKI). Study Design: Retrospective cohort study. Setting & Participants: Patients admitted to the intensive care unit (ICU) with AKI in Alberta, Can
Externí odkaz:
https://doaj.org/article/96cc01829c434137810e1ad206182784
Autor:
Ron Wald, Brian Kirkham, Bruno R. daCosta, Ehsan Ghamarian, Neill K. J. Adhikari, William Beaubien-Souligny, Rinaldo Bellomo, Martin P. Gallagher, Stuart Goldstein, Eric A. J. Hoste, Kathleen D. Liu, Javier A. Neyra, Marlies Ostermann, Paul M. Palevsky, Antoine Schneider, Suvi T. Vaara, Sean M. Bagshaw
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-11 (2022)
Abstract Background Among critically ill patients with acute kidney injury (AKI), earlier initiation of renal replacement therapy (RRT) may mitigate fluid accumulation and confer better outcomes among individuals with greater fluid overload at random
Externí odkaz:
https://doaj.org/article/b9edb07f083f4e9dba7a9cf8ec2cafaf
Autor:
Kevin Yau, Eric McArthur, Nivethika Jeyakumar, Flory Tsobo Muanda, Richard B. Kim, Kristin K. Clemens, Ron Wald, Amit X. Garg
Publikováno v:
Health Science Reports, Vol 6, Iss 6, Pp n/a-n/a (2023)
Abstract Background and Aims Quetiapine is an atypical antipsychotic predominantly metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme. We studied the risk of adverse events following coprescription of clarithromycin (a strong CYP3A4 inhibitor) ve
Externí odkaz:
https://doaj.org/article/4e99223417a646f79855523607f24565
Autor:
Fernando G. Zampieri, Bruno R. da Costa, Suvi T. Vaara, François Lamontagne, Bram Rochwerg, Alistair D. Nichol, Shay McGuinness, Danny F. McAuley, Marlies Ostermann, Ron Wald, Sean M. Bagshaw, STARRT-AKI Investigators
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-10 (2022)
Abstract Background Timing of initiation of kidney-replacement therapy (KRT) in critically ill patients remains controversial. The Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial compared
Externí odkaz:
https://doaj.org/article/6c0c4db9732b407e92ad962eefa9c5f5
Autor:
Andrea C. Cowan, Kristin K. Clemens, Jessica M. Sontrop, Stephanie N. Dixon, Lauren Killin, Sierra Anderson, Rey R. Acedillo, Amit Bagga, Clara Bohm, Pierre Antoine Brown, Brenden Cote, Varun Dev, Claire Harris, Swapnil Hiremath, Mercedeh Kiaii, Eduardo Lacson, Amber O. Molnar, Matthew J. Oliver, Malvinder S. Parmar, Jennifer M. McRae, Bharat Nathoo, Kathleen Quinn, Nikhil Shah, Samuel A. Silver, Daniel J. Tascona, Stephanie Thompson, Robert H. Ting, Marcello Tonelli, Hans Vorster, Davinder B. Wadehra, Ron Wald, Myles Wolf, Amit X. Garg
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 10 (2023)
Purpose of Review: Magnesium is an essential mineral for bone metabolism, but little is known about how magnesium intake alters fracture risk. We conducted a narrative review to better understand how magnesium intake, through supplementation, diet, o
Externí odkaz:
https://doaj.org/article/59f154d7b0534f00a276535ec2d2b6d5
Autor:
Ryan J. Chan, William Beaubien-Souligny, Samuel A. Silver, Sean M. Bagshaw, Ron Wald, Pierre-Antoine Brown, Swapnil Hiremath, Jennifer W.Y. Kong, Edward G. Clark
Publikováno v:
Kidney International Reports, Vol 7, Iss 3, Pp 614-617 (2022)
Externí odkaz:
https://doaj.org/article/dd19a4c505394dab879eb11351d14065
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 9 (2022)
Background: Online dialysis clearance monitors typically provide an accurate value for Kt. A value for V (total body water [TBW]) is required to calculate Kt/V, the measure of the adequacy of the delivered dialysis in hemodialysis (HD) patients. Usin
Externí odkaz:
https://doaj.org/article/7dd46797f7e444718c599a6a92ef8b08
Autor:
Adree Khondker, Michael Groff, Sophia Nunes, Carolyn Sun, Natasha Jawa, Jasmine Lee, Vedran Cockovski, Yasmine Hejri-Rad, Rahul Chanchlani, Adam Fleming, Amit Garg, Nivethika Jeyakumar, Abhijat Kitchlu, Asaf Lebel, Eric McArthur, Luc Mertens, Paul Nathan, Rulan Parekh, Serina Patel, Jason Pole, Raveena Ramphal, Tal Schechter, Mariana Silva, Samuel Silver, Lillian Sung, Ron Wald, Paul Gibson, Rachel Pearl, Laura Wheaton, Peter Wong, Kirby Kim, Michael Zappitelli
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 9 (2022)
Background: Approximately 30% of childhood cancer survivors (CCSs) will develop chronic kidney disease (CKD) or hypertension 15 to 20 years after treatment ends. The incidence of CKD and hypertension in the 5-year window after cancer therapy is unkno
Externí odkaz:
https://doaj.org/article/d0058a0c6d6046d79a393a2d94f55af9